Tassili Life Sciences

Toronto, Canada Founded: 2019 • Age: 7 yrs Acquired By Champignon Brands
Medical cannabis products for concussion, PTSD, and OCD are developed.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Tassili Life Sciences

Tassili Life Sciences is a company based in Toronto (Canada) founded in 2019 was acquired by Champignon Brands in March 2020. Tassili Life Sciences operates in a competitive market with competitors including ZYUS Life Sciences, Sanity Group, Terraflos, Avicanna and Little Green Pharma, among others.

  • Headquarter Toronto, Canada
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    Champignon Brands

    (Mar 30, 2020)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Tassili Life Sciences

Premium access

Detailed funding history for Tassili Life Sciences

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Tassili Life Sciences

Tassili Life Sciences has secured backing from 1 investor. Prominent investors backing the company include Champignon Brands.

All
Investor Description Founded Year Domain Location
Psychedelic formulations for mental health treatment are developed.
Locked Locked Locked
Premium access

Investor details for Tassili Life Sciences

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Tassili Life Sciences

Investments
Premium access

Investment portfolio details for Tassili Life Sciences

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Tassili Life Sciences

Premium access

Detailed financials for Tassili Life Sciences

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Tassili Life Sciences Comparisons

Tassili Life Sciences Primary company
Description
Medical cannabis products for concussion, PTSD, and OCD are ...
Location
Toronto, Canada
Founded Year
2019
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Tassili Life Sciences

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Tassili Life Sciences

Tassili Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ZYUS Life Sciences, Sanity Group, Terraflos, Avicanna and Little Green Pharma, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Cannabis-derived therapeutics for multiple indications are developed.
Locked Locked Locked
Developer of cannabinoid-based pharmaceuticals and well-being products
Locked Locked Locked
Medical cannabis products are provided based on GMP processes.
Locked Locked Locked
Plant-derived cannabinoid products are developed for medical and consumer uses.
Locked Locked Locked
Manufacturer of medicinal cannabis for therapeutic use
Locked Locked Locked
Developer of medical cannabis products
Premium access

Detailed competitors of Tassili Life Sciences

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Tassili Life Sciences

Premium access

Complete news archive for Tassili Life Sciences

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tassili Life Sciences

Tassili Life Sciences was founded in 2019.

Tassili Life Sciences is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.

Jonathan Gilbert is the current CEO of Tassili Life Sciences.

Tassili Life Sciences was founded in 2019 in Toronto, Canada, within the medical cannabis sector. Products targeting concussion syndrome, PTSD, and OCD are developed, incorporating Psilocybin and CBD dosages. Clinical results are enhanced through these formulations. Operations focus on therapeutic advancements in the cannabis industry, serving medical applications in North America.

Tassili Life Sciences's top competitors include Avicanna, ZYUS Life Sciences and Neocannbio.

Tassili Life Sciences has 1 investor. Key investors include Champignon Brands.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available